Number of employees
100
Annual revenue
$37000000
Fujirebio Diagnostics, Inc. (FDI), is a premier diagnostics company and the industry leader in the development of Tumor Marker assays. FDI specializes in the clinical development, manufacturing and commercialization of in vitro diagnostic products for the detection, prognosis, and monitoring of human disease states with an emphasis in Oncology.